Stock Research for ALKS

ALKS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALKS Stock Chart & Research Data

The ALKS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALKS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALKS Due diligence Resources & Stock Charts

The ALKS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALKS Detailed Price Forecast - CNN Money CNN View ALKS Detailed Summary - Google Finance
Yahoo View ALKS Detailed Summary - Yahoo! Finance Zacks View ALKS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALKS Trends & Analysis - Trade-Ideas Barrons View ALKS Major Holders - Barrons
NASDAQ View ALKS Call Transcripts - NASDAQ Seeking View ALKS Breaking News & Analysis - Seeking Alpha
Spotlight View ALKS Annual Report - CompanySpotlight.com OTC Report View ALKS OTC Short Report - OTCShortReport.com
TradeKing View ALKS Fundamentals - TradeKing Charts View ALKS SEC Filings - Bar Chart
WSJ View Historical Prices for ALKS - The WSJ Morningstar View Performance/Total Return for ALKS - Morningstar
MarketWatch View the Analyst Estimates for ALKS - MarketWatch CNBC View the Earnings History for ALKS - CNBC
StockMarketWatch View the ALKS Earnings - StockMarketWatch MacroAxis View ALKS Buy or Sell Recommendations - MacroAxis
Bullish View the ALKS Bullish Patterns - American Bulls Short Pains View ALKS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALKS Stock Mentions - StockTwits PennyStocks View ALKS Stock Mentions - PennyStockTweets
Twitter View ALKS Stock Mentions - Twitter Invest Hub View ALKS Investment Forum News - Investor Hub
Yahoo View ALKS Stock Mentions - Yahoo! Message Board Seeking Alpha View ALKS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALKS - SECform4.com Insider Cow View Insider Transactions for ALKS - Insider Cow
CNBC View ALKS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALKS - OTC Markets
Yahoo View Insider Transactions for ALKS - Yahoo! Finance NASDAQ View Institutional Holdings for ALKS - NASDAQ


Stock Charts

FinViz View ALKS Stock Insight & Charts - FinViz.com StockCharts View ALKS Investment Charts - StockCharts.com
BarChart View ALKS Stock Overview & Charts - BarChart Trading View View ALKS User Generated Charts - Trading View




Latest Financial News for ALKS


Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?
Posted on Wednesday September 18, 2019

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...


Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $2.3 million of Shares
Posted on Friday September 13, 2019

Director and CEO, Alkermes plc of Alkermes Plc (30-Year Financial, Insider Trades) Richard F Pops (insider trades) sold 100,000 shares of ALKS on 09/12/2019 at an average price of $22.68 a share. Continue reading...


Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D.
Posted on Friday September 13, 2019

DUBLIN, Sept. 13, 2019 /PRNewswire/ -- Alkermes plc (ALKS) today announced the appointment of two new independent directors, Richard Gaynor, M.D. and Frank Anders (Andy) Wilson, to the company's Board of Directors. The company also announced the retirement of Floyd Bloom, M.D., a pioneer in the field of neuroscience who contributed immensely to the legacy of innovation and scientific excellence that remains core to Alkermes' mission today. Dr. Gaynor, who currently serves as the President of Research & Development at Neon Therapeutics, brings 18 years of experience in oncology-focused industrial drug development in addition to a distinguished career in academic medicine.


Why Is Alkermes (ALKS) Down 3.9% Since Last Earnings Report?
Posted on Saturday August 24, 2019

Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.